Season 1, Episode 20
May 14, 2020•16 min
Episode description
In this week’s episode we’ll learn why anticoagulation may play a role in the prevention of vaso-occlusive events in sickle cell disease, review data that could help predict the risk of VTE and bleeding in hospitalized patients, and find out if Ruxolitinib is a viable treatment of steroid-refractory acute graft-versus-host disease.
For the best experience, listen in Metacast app for iOS or Android
